DHC - Diversified Healthcare Trust
NASDAQ
->
Real Estate
->
REIT—Healthcare Facilities
Newton,
United States
Type: Equity
DHC price evolution
DHC
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $270.08 | $208.16 | $246.96 | |
| Short term investments | ||||
| Net receivables | $6.08 | |||
| Inventory | ||||
| Total current assets | $256.53 | $265.56 | $207.12 | $252.02 |
| Long term investments | ||||
| Property, plant & equipment | $4582.86 | $4698.95 | $4747.03 | $4807.07 |
| Goodwill & intangible assets | $29.66 | $31.72 | $33.95 | |
| Total noncurrent assets | ||||
| Total investments | $133.71 | $146.04 | $129.92 | |
| Total assets | $5285.2 | $5333.45 | $5348.04 | $5446.14 |
| Current liabilities | ||||
| Accounts payable | $7.06 | |||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $43.84 | $45.31 | $46.69 | $53.66 |
| Long term debt | $2945.29 | $2919.91 | $2837.84 | $2816.85 |
| Total noncurrent liabilities | ||||
| Total debt | $2919.91 | $2837.84 | $2816.85 | |
| Total liabilities | $3236.79 | $3184.13 | $3099.33 | $3109.24 |
| Shareholders' equity | ||||
| Retained earnings | -$2574.01 | -$2472.91 | -$2372.65 | -$2283.98 |
| Other shareholder equity | $0.01 | -$0.03 | -$0 | |
| Total shareholder equity | $2149.31 | $2248.7 | $2336.89 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $246.96 | $688.3 | $1016.95 | $90.85 |
| Short term investments | ||||
| Net receivables | $6.08 | $8.72 | ||
| Inventory | ||||
| Total current assets | $252.02 | $666.78 | $634.85 | $203.29 |
| Long term investments | $73.78 | |||
| Property, plant & equipment | $4807.07 | $4890.7 | $5075.75 | $5828.27 |
| Goodwill & intangible assets | $33.95 | $45.35 | $48.75 | $286.51 |
| Total noncurrent assets | ||||
| Total investments | $129.92 | $161.36 | $246.67 | $73.77 |
| Total assets | $5446.14 | $6002.09 | $6623.51 | $6476.42 |
| Current liabilities | ||||
| Accounts payable | $7.06 | $5.2 | $8.27 | $24.55 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $53.66 | $61.51 | $42.47 | $27.3 |
| Long term debt | $2816.85 | $3047.88 | $3676.52 | $3498.81 |
| Total noncurrent liabilities | ||||
| Total debt | $2816.85 | $3047.88 | $3676.52 | $3498.81 |
| Total liabilities | $3109.24 | $3363.48 | $3961.12 | $3857.2 |
| Shareholders' equity | ||||
| Retained earnings | -$2283.98 | -$1980.82 | -$1955.47 | -$2120.45 |
| Other shareholder equity | -$3910.17 | |||
| Total shareholder equity | $2336.89 | $2638.61 | $2662.39 | $2495.84 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $371.39 | $370.78 | $361.54 | |
| Cost of revenue | $304.06 | $307.6 | $303.41 | |
| Gross Profit | $67.33 | $63.17 | $58.12 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $6.26 | $7.57 | $6.02 | |
| Total operating expenses | $96.2 | $95.8 | $90.74 | |
| Operating income | -$28.88 | -$32.63 | -$32.62 | |
| Income from continuing operations | ||||
| EBIT | -$38.99 | -$28.5 | -$53.65 | |
| Income tax expense | $0.17 | $0.19 | $0.07 | |
| Interest expense | $58.7 | $57.58 | $48.85 | |
| Net income | ||||
| Net income | -$97.86 | -$86.26 | -$102.56 | |
| Income (for common shares) | -$97.86 | -$86.26 | -$102.56 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1410.31 | $1283.57 | $1383.21 | $1632.03 |
| Cost of revenue | $1174.15 | $1109.07 | $1091.81 | $1236.36 |
| Gross Profit | $236.16 | $174.5 | $291.4 | $395.67 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $26.13 | $26.43 | $34.09 | $30.59 |
| Total operating expenses | $338.24 | -$53.54 | -$169.72 | $402.04 |
| Operating income | -$102.08 | $228.04 | $461.12 | -$6.37 |
| Income from continuing operations | ||||
| EBIT | -$101.35 | $194.32 | $431.7 | $63.28 |
| Income tax expense | $0.45 | $0.71 | $1.43 | $1.25 |
| Interest expense | $191.78 | $209.38 | $255.76 | $201.48 |
| Net income | ||||
| Net income | -$293.57 | -$15.77 | $174.51 | -$139.45 |
| Income (for common shares) | -$293.57 | -$15.77 | $174.51 | -$139.45 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$97.86 | -$86.26 | -$102.56 | |
| Operating activities | ||||
| Depreciation | $68.36 | $70.13 | $83.41 | |
| Business acquisitions & disposals | -$15.46 | |||
| Stock-based compensation | ||||
| Total cash flows from operations | $44.29 | $28.6 | -$7.21 | |
| Investing activities | ||||
| Capital expenditures | -$37.02 | -$43.38 | -$51.8 | |
| Investments | ||||
| Total cash flows from investing | -$120.88 | -$36.85 | -$58.84 | -$51.27 |
| Financing activities | ||||
| Dividends paid | -$7.21 | -$2.4 | -$2.4 | -$2.4 |
| Sale and purchase of stock | -$0.04 | -$0.08 | -$0.01 | |
| Net borrowings | $56.93 | -$6.08 | $29.72 | |
| Total cash flows from financing | $41.29 | $54.48 | -$8.56 | $26.33 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $14.44 | $61.92 | -$38.8 | -$32.14 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$293.57 | -$15.77 | $174.51 | -$139.45 |
| Operating activities | ||||
| Depreciation | $283.84 | $239.28 | $271.13 | $270.15 |
| Business acquisitions & disposals | $14.01 | $746.91 | $367.04 | $0.29 |
| Stock-based compensation | ||||
| Total cash flows from operations | $10.48 | -$40.35 | -$63.32 | $158.54 |
| Investing activities | ||||
| Capital expenditures | -$216.65 | -$373.67 | -$124.35 | -$40.72 |
| Investments | ||||
| Total cash flows from investing | -$202.11 | $387.71 | $242.7 | -$40.44 |
| Financing activities | ||||
| Dividends paid | -$9.6 | -$9.57 | -$9.54 | -$42.83 |
| Sale and purchase of stock | -$0.39 | -$0.17 | -$0.38 | -$0.17 |
| Net borrowings | -$238.75 | -$641.88 | $778.99 | -$13.82 |
| Total cash flows from financing | -$249.71 | -$676 | $746.72 | -$79.48 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$441.34 | -$328.64 | $926.1 | $38.63 |
News
Fundamentals
| Market cap | $1.13B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 241.28M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.33 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 5.85 |
| Quick ratio | N/A |